DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Johnson & Johnson (NYSE: JNJ)

103.73 0.78 (0.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

JNJ $103.73 0.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $103.10
Previous Close $102.95
Daily Range $103.01 - $103.76
52-Week Range $85.50 - $106.74
Market Cap $292.5B
P/E Ratio 19.17
Dividend (Yield) $2.80 (2.7%)
Ex-Dividend Date
Dividend Pay Date
08/22/14
09/09/14
Volume 5,287,778
Average Daily Volume 5,763,083
Current FY EPS $5.92

Sector

Healthcare

Industry

Drugs

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website: http://www.jnj.com/

News & Commentary

1 Strong Dividend Stock You Can Buy Right Now

Bank certificates of deposit and savings accounts pay almost nothing in interest right now. Fortunately, investors on the hunt for income don't need to gamble on the riskiest stocks out there.

Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza

Bank Of America Remains Optimistic On Johnson & Johnson

Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson

Will Johnson & Johnson (JNJ) Stock Benefit From Cordis Unit Sale?

Stock Market Today: Futures Rise on Bets of Renewed ECB Stimulus

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Why Johnson & Johnson (JNJ) Stock Is Declining Today

UPDATE 1-FDA says Johnson & Johnson recalls some jaw implants

Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences

European approval of Bristol-Myers Squibb's Daklinza could derail sales of Johnson & Johnson's Olysio, but is unlikely to unseat Gilead's Sovaldi.

See More JNJ News...

JNJ's Top Competitors

JNJ $103.73 (0.76%)
Current stock: JNJ
PFE $29.39 (0.03%)
Current stock: PFE
MRK $60.11 (0.18%)
Current stock: MRK
BSX $12.68 (2.67%)
Current stock: BSX